[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global RNA Drugs Sales Market Report 2017

August 2017 | 114 pages | ID: GB4E0B41AAAEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global RNA Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of RNA Drugs for these regions, from 2012 to 2022 (forecast), covering
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Global RNA Drugs market competition by top manufacturers/players, with RNA Drugs sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Pfizer
  • Roche
  • Sanofi-Aventis
  • Abbott Laboratories
  • Arrowhead Pharmaceuticals
  • Benitec Biopharma
  • Calimmune Inc
  • Dicerna
  • Gradalis
  • Quark
  • RXi
  • Senesco
  • Silence Therapeutics
  • Silenseed
  • Tekmira
  • Alnylam Pharmaceuticals
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
  • siRNA
  • ASO
  • miRNA
  • Nucleic Acid Aptamers
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of RNA Drugs for each application, including
  • Cancer
  • Diabetes
  • Tuberculosis
  • Cardiovascular Diseases
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Global RNA Drugs Sales Market Report 2017

1 RNA DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of RNA Drugs
1.2 Classification of RNA Drugs by Product Category
  1.2.1 Global RNA Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global RNA Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 siRNA
  1.2.4 ASO
  1.2.5 miRNA
  1.2.6 Nucleic Acid Aptamers
1.3 Global RNA Drugs Market by Application/End Users
  1.3.1 Global RNA Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Cancer
  1.3.3 Diabetes
  1.3.4 Tuberculosis
  1.3.5 Cardiovascular Diseases
  1.3.6 Others
1.4 Global RNA Drugs Market by Region
  1.4.1 Global RNA Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States RNA Drugs Status and Prospect (2012-2022)
  1.4.3 China RNA Drugs Status and Prospect (2012-2022)
  1.4.4 Europe RNA Drugs Status and Prospect (2012-2022)
  1.4.5 Japan RNA Drugs Status and Prospect (2012-2022)
  1.4.6 Southeast Asia RNA Drugs Status and Prospect (2012-2022)
  1.4.7 India RNA Drugs Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of RNA Drugs (2012-2022)
  1.5.1 Global RNA Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Global RNA Drugs Revenue and Growth Rate (2012-2022)

2 GLOBAL RNA DRUGS COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global RNA Drugs Market Competition by Players/Suppliers
  2.1.1 Global RNA Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global RNA Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global RNA Drugs (Volume and Value) by Type
  2.2.1 Global RNA Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Global RNA Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global RNA Drugs (Volume and Value) by Region
  2.3.1 Global RNA Drugs Sales and Market Share by Region (2012-2017)
  2.3.2 Global RNA Drugs Revenue and Market Share by Region (2012-2017)
2.4 Global RNA Drugs (Volume) by Application

3 UNITED STATES RNA DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States RNA Drugs Sales and Value (2012-2017)
  3.1.1 United States RNA Drugs Sales and Growth Rate (2012-2017)
  3.1.2 United States RNA Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 United States RNA Drugs Sales Price Trend (2012-2017)
3.2 United States RNA Drugs Sales Volume and Market Share by Players
3.3 United States RNA Drugs Sales Volume and Market Share by Type
3.4 United States RNA Drugs Sales Volume and Market Share by Application

4 CHINA RNA DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China RNA Drugs Sales and Value (2012-2017)
  4.1.1 China RNA Drugs Sales and Growth Rate (2012-2017)
  4.1.2 China RNA Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 China RNA Drugs Sales Price Trend (2012-2017)
4.2 China RNA Drugs Sales Volume and Market Share by Players
4.3 China RNA Drugs Sales Volume and Market Share by Type
4.4 China RNA Drugs Sales Volume and Market Share by Application

5 EUROPE RNA DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe RNA Drugs Sales and Value (2012-2017)
  5.1.1 Europe RNA Drugs Sales and Growth Rate (2012-2017)
  5.1.2 Europe RNA Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 Europe RNA Drugs Sales Price Trend (2012-2017)
5.2 Europe RNA Drugs Sales Volume and Market Share by Players
5.3 Europe RNA Drugs Sales Volume and Market Share by Type
5.4 Europe RNA Drugs Sales Volume and Market Share by Application

6 JAPAN RNA DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan RNA Drugs Sales and Value (2012-2017)
  6.1.1 Japan RNA Drugs Sales and Growth Rate (2012-2017)
  6.1.2 Japan RNA Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Japan RNA Drugs Sales Price Trend (2012-2017)
6.2 Japan RNA Drugs Sales Volume and Market Share by Players
6.3 Japan RNA Drugs Sales Volume and Market Share by Type
6.4 Japan RNA Drugs Sales Volume and Market Share by Application

7 SOUTHEAST ASIA RNA DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia RNA Drugs Sales and Value (2012-2017)
  7.1.1 Southeast Asia RNA Drugs Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia RNA Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia RNA Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia RNA Drugs Sales Volume and Market Share by Players
7.3 Southeast Asia RNA Drugs Sales Volume and Market Share by Type
7.4 Southeast Asia RNA Drugs Sales Volume and Market Share by Application

8 INDIA RNA DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 India RNA Drugs Sales and Value (2012-2017)
  8.1.1 India RNA Drugs Sales and Growth Rate (2012-2017)
  8.1.2 India RNA Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 India RNA Drugs Sales Price Trend (2012-2017)
8.2 India RNA Drugs Sales Volume and Market Share by Players
8.3 India RNA Drugs Sales Volume and Market Share by Type
8.4 India RNA Drugs Sales Volume and Market Share by Application

9 GLOBAL RNA DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Pfizer
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 RNA Drugs Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Pfizer RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Roche
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 RNA Drugs Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Roche RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Sanofi-Aventis
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 RNA Drugs Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Sanofi-Aventis RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Abbott Laboratories
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 RNA Drugs Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Abbott Laboratories RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Arrowhead Pharmaceuticals
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 RNA Drugs Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Arrowhead Pharmaceuticals RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Benitec Biopharma
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 RNA Drugs Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Benitec Biopharma RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Calimmune Inc
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 RNA Drugs Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Calimmune Inc RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Dicerna
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 RNA Drugs Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Dicerna RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Gradalis
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 RNA Drugs Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Gradalis RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Quark
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 RNA Drugs Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Quark RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 RXi
9.12 Senesco
9.13 Silence Therapeutics
9.14 Silenseed
9.15 Tekmira
9.16 Alnylam Pharmaceuticals

10 RNA DRUGS MAUFACTURING COST ANALYSIS

10.1 RNA Drugs Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of RNA Drugs
10.3 Manufacturing Process Analysis of RNA Drugs

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 RNA Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of RNA Drugs Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL RNA DRUGS MARKET FORECAST (2017-2022)

14.1 Global RNA Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global RNA Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global RNA Drugs Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global RNA Drugs Price and Trend Forecast (2017-2022)
14.2 Global RNA Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global RNA Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global RNA Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States RNA Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China RNA Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe RNA Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan RNA Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia RNA Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India RNA Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global RNA Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global RNA Drugs Sales Forecast by Type (2017-2022)
  14.3.2 Global RNA Drugs Revenue Forecast by Type (2017-2022)
  14.3.3 Global RNA Drugs Price Forecast by Type (2017-2022)
14.4 Global RNA Drugs Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of RNA Drugs
Figure Global RNA Drugs Sales Volume Comparison (K Units) by Type (2012-2022)
Figure Global RNA Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure siRNA Product Picture
Figure ASO Product Picture
Figure miRNA Product Picture
Figure Nucleic Acid Aptamers Product Picture
Figure Global RNA Drugs Sales Comparison (K Units) by Application (2012-2022)
Figure Global Sales Market Share of RNA Drugs by Application in 2016
Figure Cancer Examples
Table Key Downstream Customer in Cancer
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Tuberculosis Examples
Table Key Downstream Customer in Tuberculosis
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global RNA Drugs Market Size (Million USD) by Regions (2012-2022)
Figure United States RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global RNA Drugs Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Global RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players RNA Drugs Sales Volume (K Units) (2012-2017)
Table Global RNA Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Global RNA Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 RNA Drugs Sales Share by Players/Suppliers
Figure 2017 RNA Drugs Sales Share by Players/Suppliers
Figure Global RNA Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global RNA Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global RNA Drugs Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global RNA Drugs Revenue Share by Players
Table 2017 Global RNA Drugs Revenue Share by Players
Table Global RNA Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table Global RNA Drugs Sales Share (K Units) by Type (2012-2017)
Figure Sales Market Share of RNA Drugs by Type (2012-2017)
Figure Global RNA Drugs Sales Growth Rate by Type (2012-2017)
Table Global RNA Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global RNA Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of RNA Drugs by Type (2012-2017)
Figure Global RNA Drugs Revenue Growth Rate by Type (2012-2017)
Table Global RNA Drugs Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Global RNA Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of RNA Drugs by Region (2012-2017)
Figure Global RNA Drugs Sales Growth Rate by Region in 2016
Table Global RNA Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global RNA Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of RNA Drugs by Region (2012-2017)
Figure Global RNA Drugs Revenue Growth Rate by Region in 2016
Table Global RNA Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global RNA Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of RNA Drugs by Region (2012-2017)
Figure Global RNA Drugs Revenue Market Share by Region in 2016
Table Global RNA Drugs Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Global RNA Drugs Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of RNA Drugs by Application (2012-2017)
Figure Global RNA Drugs Sales Market Share by Application (2012-2017)
Figure United States RNA Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure United States RNA Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States RNA Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table United States RNA Drugs Sales Volume (K Units) by Players (2012-2017)
Table United States RNA Drugs Sales Volume Market Share by Players (2012-2017)
Figure United States RNA Drugs Sales Volume Market Share by Players in 2016
Table United States RNA Drugs Sales Volume (K Units) by Type (2012-2017)
Table United States RNA Drugs Sales Volume Market Share by Type (2012-2017)
Figure United States RNA Drugs Sales Volume Market Share by Type in 2016
Table United States RNA Drugs Sales Volume (K Units) by Application (2012-2017)
Table United States RNA Drugs Sales Volume Market Share by Application (2012-2017)
Figure United States RNA Drugs Sales Volume Market Share by Application in 2016
Figure China RNA Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure China RNA Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China RNA Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table China RNA Drugs Sales Volume (K Units) by Players (2012-2017)
Table China RNA Drugs Sales Volume Market Share by Players (2012-2017)
Figure China RNA Drugs Sales Volume Market Share by Players in 2016
Table China RNA Drugs Sales Volume (K Units) by Type (2012-2017)
Table China RNA Drugs Sales Volume Market Share by Type (2012-2017)
Figure China RNA Drugs Sales Volume Market Share by Type in 2016
Table China RNA Drugs Sales Volume (K Units) by Application (2012-2017)
Table China RNA Drugs Sales Volume Market Share by Application (2012-2017)
Figure China RNA Drugs Sales Volume Market Share by Application in 2016
Figure Europe RNA Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe RNA Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe RNA Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Europe RNA Drugs Sales Volume (K Units) by Players (2012-2017)
Table Europe RNA Drugs Sales Volume Market Share by Players (2012-2017)
Figure Europe RNA Drugs Sales Volume Market Share by Players in 2016
Table Europe RNA Drugs Sales Volume (K Units) by Type (2012-2017)
Table Europe RNA Drugs Sales Volume Market Share by Type (2012-2017)
Figure Europe RNA Drugs Sales Volume Market Share by Type in 2016
Table Europe RNA Drugs Sales Volume (K Units) by Application (2012-2017)
Table Europe RNA Drugs Sales Volume Market Share by Application (2012-2017)
Figure Europe RNA Drugs Sales Volume Market Share by Application in 2016
Figure Japan RNA Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Japan RNA Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan RNA Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Japan RNA Drugs Sales Volume (K Units) by Players (2012-2017)
Table Japan RNA Drugs Sales Volume Market Share by Players (2012-2017)
Figure Japan RNA Drugs Sales Volume Market Share by Players in 2016
Table Japan RNA Drugs Sales Volume (K Units) by Type (2012-2017)
Table Japan RNA Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan RNA Drugs Sales Volume Market Share by Type in 2016
Table Japan RNA Drugs Sales Volume (K Units) by Application (2012-2017)
Table Japan RNA Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan RNA Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia RNA Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia RNA Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia RNA Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia RNA Drugs Sales Volume (K Units) by Players (2012-2017)
Table Southeast Asia RNA Drugs Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia RNA Drugs Sales Volume Market Share by Players in 2016
Table Southeast Asia RNA Drugs Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia RNA Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia RNA Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia RNA Drugs Sales Volume (K Units) by Application (2012-2017)
Table Southeast Asia RNA Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia RNA Drugs Sales Volume Market Share by Application in 2016
Figure India RNA Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure India RNA Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India RNA Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table India RNA Drugs Sales Volume (K Units) by Players (2012-2017)
Table India RNA Drugs Sales Volume Market Share by Players (2012-2017)
Figure India RNA Drugs Sales Volume Market Share by Players in 2016
Table India RNA Drugs Sales Volume (K Units) by Type (2012-2017)
Table India RNA Drugs Sales Volume Market Share by Type (2012-2017)
Figure India RNA Drugs Sales Volume Market Share by Type in 2016
Table India RNA Drugs Sales Volume (K Units) by Application (2012-2017)
Table India RNA Drugs Sales Volume Market Share by Application (2012-2017)
Figure India RNA Drugs Sales Volume Market Share by Application in 2016
Table Pfizer Basic Information List
Table Pfizer RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer RNA Drugs Sales Growth Rate (2012-2017)
Figure Pfizer RNA Drugs Sales Global Market Share (2012-2017
Figure Pfizer RNA Drugs Revenue Global Market Share (2012-2017)
Table Roche Basic Information List
Table Roche RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche RNA Drugs Sales Growth Rate (2012-2017)
Figure Roche RNA Drugs Sales Global Market Share (2012-2017
Figure Roche RNA Drugs Revenue Global Market Share (2012-2017)
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi-Aventis RNA Drugs Sales Growth Rate (2012-2017)
Figure Sanofi-Aventis RNA Drugs Sales Global Market Share (2012-2017
Figure Sanofi-Aventis RNA Drugs Revenue Global Market Share (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories RNA Drugs Sales Growth Rate (2012-2017)
Figure Abbott Laboratories RNA Drugs Sales Global Market Share (2012-2017
Figure Abbott Laboratories RNA Drugs Revenue Global Market Share (2012-2017)
Table Arrowhead Pharmaceuticals Basic Information List
Table Arrowhead Pharmaceuticals RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Arrowhead Pharmaceuticals RNA Drugs Sales Growth Rate (2012-2017)
Figure Arrowhead Pharmaceuticals RNA Drugs Sales Global Market Share (2012-2017
Figure Arrowhead Pharmaceuticals RNA Drugs Revenue Global Market Share (2012-2017)
Table Benitec Biopharma Basic Information List
Table Benitec Biopharma RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Benitec Biopharma RNA Drugs Sales Growth Rate (2012-2017)
Figure Benitec Biopharma RNA Drugs Sales Global Market Share (2012-2017
Figure Benitec Biopharma RNA Drugs Revenue Global Market Share (2012-2017)
Table Calimmune Inc Basic Information List
Table Calimmune Inc RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Calimmune Inc RNA Drugs Sales Growth Rate (2012-2017)
Figure Calimmune Inc RNA Drugs Sales Global Market Share (2012-2017
Figure Calimmune Inc RNA Drugs Revenue Global Market Share (2012-2017)
Table Dicerna Basic Information List
Table Dicerna RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dicerna RNA Drugs Sales Growth Rate (2012-2017)
Figure Dicerna RNA Drugs Sales Global Market Share (2012-2017
Figure Dicerna RNA Drugs Revenue Global Market Share (2012-2017)
Table Gradalis Basic Information List
Table Gradalis RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Gradalis RNA Drugs Sales Growth Rate (2012-2017)
Figure Gradalis RNA Drugs Sales Global Market Share (2012-2017
Figure Gradalis RNA Drugs Revenue Global Market Share (2012-2017)
Table Quark Basic Information List
Table Quark RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Quark RNA Drugs Sales Growth Rate (2012-2017)
Figure Quark RNA Drugs Sales Global Market Share (2012-2017
Figure Quark RNA Drugs Revenue Global Market Share (2012-2017)
Table RXi Basic Information List
Table Senesco Basic Information List
Table Silence Therapeutics Basic Information List
Table Silenseed Basic Information List
Table Tekmira Basic Information List
Table Alnylam Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of RNA Drugs
Figure Manufacturing Process Analysis of RNA Drugs
Figure RNA Drugs Industrial Chain Analysis
Table Raw Materials Sources of RNA Drugs Major Players in 2016
Table Major Buyers of RNA Drugs
Table Distributors/Traders List
Figure Global RNA Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Global RNA Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global RNA Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table Global RNA Drugs Sales Volume (K Units) Forecast by Regions (2017-2022)
Figure Global RNA Drugs Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global RNA Drugs Sales Volume Market Share Forecast by Regions in 2022
Table Global RNA Drugs Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global RNA Drugs Revenue Market Share Forecast by Regions (2017-2022)
Figure Global RNA Drugs Revenue Market Share Forecast by Regions in 2022
Figure United States RNA Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States RNA Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China RNA Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure China RNA Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Europe RNA Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe RNA Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan RNA Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan RNA Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia RNA Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia RNA Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India RNA Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure India RNA Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global RNA Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure Global RNA Drugs Sales Volume Market Share Forecast by Type (2017-2022)
Table Global RNA Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global RNA Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global RNA Drugs Price (USD/Unit) Forecast by Type (2017-2022)
Table Global RNA Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure Global RNA Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories